Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myotonic Dystrophy Type 1 and Type 2”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Testing effectiveness (Phase 2)Looking for participantsNCT06844214
What this trial is testing

Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 50 Years of Age With Non-congenital Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy
Sanofi 32
Testing effectiveness (Phase 2)Study completedNCT05479981
What this trial is testing

Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients

Who this might be right for
DM1Muscular DystrophiesMyotonic Dystrophy+10 more
Avidity Biosciences, Inc. 37
Large-scale testing (Phase 3)WithdrawnNCT04700046
What this trial is testing

Study to Investigate the Efficacy and Safety of Mexiletine in Patients With Myotonic Dystrophy Type 1 and Type 2

Who this might be right for
Myotonic Dystrophy Type 1 and Type 2
Lupin Ltd.
Testing effectiveness (Phase 2)Study completedNCT05027269
What this trial is testing

Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients

Who this might be right for
DM1Myotonic Dystrophy 1Myotonic Dystrophy+5 more
Avidity Biosciences, Inc. 38
Not applicableEnrolling By InvitationNCT07072676
What this trial is testing

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

Who this might be right for
Inclusion Body MyositisMyotonic Dystrophy 1Myotonic Dystrophy 2+10 more
LMU Klinikum 30
Testing effectiveness (Phase 2)Looking for participantsNCT06667453
What this trial is testing

A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy 1
PepGen Inc 24
Not applicableUnknownNCT03155594
What this trial is testing

CGM to Aid Transition From Inpatient to Outpatient

Who this might be right for
Diabete Mellitus
Methodist Medical Center of Illinois 15
Not applicableStudy completedNCT04907162
What this trial is testing

Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders

Who this might be right for
Pompe Disease (Late-onset)Myotonic Dystrophy Type 1 (DM1)Myotonic Dystrophy Type 2+4 more
LMU Klinikum 82
Early research (Phase 1)Study completedNCT00346255
What this trial is testing

BB-10901 in Treating Patients With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
ImmunoGen, Inc. 37
Large-scale testing (Phase 3)Enrolling By InvitationNCT06549400
What this trial is testing

An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2 Who Have Completed MEX-DM-302 Study.

Who this might be right for
Myotonic Dystrophy
Lupin Ltd. 176
Not applicableStudy completedNCT03087526
What this trial is testing

NIPD on CFTC for Triplet Repeat Diseases

Who this might be right for
Non Invasive Prenatal Diagnosis
University Hospital, Montpellier 60
Not applicableLooking for participantsNCT04003363
What this trial is testing

The United Kingdom National Registry for Myotonic Dystrophy

Who this might be right for
Myotonic Dystrophy
Newcastle University 900
Not applicableLooking for participantsNCT07136844
What this trial is testing

Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology

Who this might be right for
Neuromuscular DiseasesObesity (Disorder)Myotonic Dystrophy 1+9 more
Centre Hospitalier Universitaire de Liege 300
Not applicableLooking for participantsNCT06708468
What this trial is testing

Personalized Training for People With Rare Neuromuscular Disorders

Who this might be right for
Neuromuscular Diseases (NMD)Charcot Marie Tooth Disease (CMT)Facioscapulohumeral Muscular Dystrophy+1 more
Oslo University Hospital 120
Large-scale testing (Phase 3)Looking for participantsNCT06523400
What this trial is testing

The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2

Who this might be right for
Myotonic Dystrophy
Lupin Ltd. 176
Testing effectiveness (Phase 2)Looking for participantsNCT06185764
What this trial is testing

VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)

Who this might be right for
Myotonic Dystrophy Type 1 (DM1)
Vertex Pharmaceuticals Incorporated 36
Not applicableLooking for participantsNCT05854433
What this trial is testing

Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2

Who this might be right for
Myotonic Dystrophy Type 2Myotonic Dystrophy Type 1
Wake Forest University Health Sciences 100
Not applicableLooking for participantsNCT00082108
What this trial is testing

Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry

Who this might be right for
Myotonic DystrophyFacioscapulohumeral Muscular DystrophyMuscular Dystrophy+6 more
University of Rochester 3,000
Large-scale testing (Phase 3)Study completedNCT01421992
What this trial is testing

Methylphenidate in Myotonic Dystrophy Type 1

Who this might be right for
Dystrophia Myotonica 1
Laval University 28
Very early researchNot Yet RecruitingNCT06828588
What this trial is testing

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

Who this might be right for
Locally Advanced CancerMetastatic CancerHER2+2 more
Vanderbilt-Ingram Cancer Center 30